抗生素耐药细菌治疗产品的高级开发-猫眼课题宝

抗生素耐药细菌治疗产品的高级开发

批准号：

10329726

负责人：

URS OCHSNER

金额：

$85.05万

依托单位：

CRESTONE, INC.

依托单位国家：

美国

项目类别：

财政年份：

2019

资助国家：

美国

项目状态：

已结题

起止时间：

2019-09-09 至 2022-03-11

来源：

https://reporter.nih.gov/project-details/10329726

关键词：

Advanced Development Antimicrobial Resistance Bacterial Antibiotic Resistance Clinical Clostridium difficile Development Gram-Positive Bacteria Pathway interactions Phase II Clinical Trials Testing efficacy evaluation pre-clinical product development research and development safety assessment therapeutic candidate therapeutic development

项目摘要

项目成果

URS OCHSNER的其他基金

相似基金

相关文献

中文摘要

翻译

点击翻译按钮获取中文摘要

英文摘要

To support the advanced development of a promising candidate therapeutic. The research and development activities to be supported will allow the candidate therapeutic product to progress along the product development pathway, and include preclinical and IND enabling development activities, and clinical safety and efficacy assessment. Support includes a Phase II clinical trial.

期刊论文(0)

专著(0)

科研奖励(0)

会议论文